Beverly Moy

15PUBLICATIONS
82CO-AUTHORS
Preventative health careCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jan 28, 2026
Guidance for Community Engagement With Underserved Populations in Cancer Care.

Quinn S Solfisburg, Suzanne Vang, Victoria Foster

|Jan 27, 2025
Impact of Race/Ethnicity on Clinical and Genomic Characteristics, Trial Participation, and Genotype-Matched Therapy among Patients with Metastatic Breast Cancer.

Rupali Sood, Andrzej Niemierko, Lianne Ryan

|Jan 02, 2025
TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.

Rachel O Abelman, Bogang Wu, Haley Barnes

|Nov 12, 2024
Deficits of Molecular Prognosis/Diagnosis Studies in Underserved Populations.

Arielle J Medford, Beverly Moy

|May 06, 2024
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer.

Aditya Bardia, Sheng Sun, Nayana Thimmiah

Pageof 3